Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
New Choosing Wisely Guidance on BMT Released
Biol Blood Marrow Transplant; ePub 2018 Jan 19; Bhella, et al
The American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group have released guidance on the top 5 practices in blood and marrow transplantation to question. The recommendations—released in conjunction with the Choosing Wisely BMT program—focus on the following areas:
- Graft source for patients with aplastic anemia.
- Corticosteroid dose for initial treatment of graft-vs-host-disease.
- Optimal number of umbilical cord blood units for transplantation.
- Graft source in matched unrelated donor transplantation.
- Use of prophylactic intravenous immunoglobulin in transplant recipients.
The guidance focuses on tests, treatments, or procedures that may be harmful, wasteful, or for which there is no apparent clinical benefit.
Bhella S, Majhail N, Betcher J, et al. Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group’s list of five tests and treatments to question in blood and marrow transplantation. [Published online ahead of print January 19, 2018]. Biol Blood Marrow Transplant. doi:10.1016/j.bbmt.2018.01.017.